Via a dual‐targeting mechanism and responsive PD‐L1 antibody release, this nanoplatform enables amplified sonodynamic‐chemodynamic therapy and elicits robust immune response for eradicating metastatic tumors. This evidence concerns the gene CD274 and metastatic neoplasm.